About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Approaches in Advanced RCC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
V
Updated Results From the CLEAR Trial: Outcomes of the Combination of Lenvatinib & Pembrolizumab as 1L Therapy in Advanced RCC
By
Viktor Grünwald
11 Videos
908 views
April 21, 2023
0 Comments
Login to view comments.
Click here to Login
11:38
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR -…
Feat.
T. Hutson
11:46
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Te…
Feat.
S. Gupta
07:42
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Analysis of Pt-Level Data From SWOG-1216 …
Feat.
N. Sayegh
23:57
ecancer
ASCO® 2023 Summary: "Key Trials in mRCC"
Feat.
J. Puente,
C. Suárez,
S. Oudard,
V. Grünwald
19:50
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Adding Clarity to Non-Clear Cell Carcinom…
Feat.
M. Schmidinger
08:22
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzum…
Feat.
S. Tagawa
05:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "FGFR3 Alterations in Phase III PROOF 302 …
Feat.
P. Grivas
17:19
The University of Kansas Cancer Center
The Role of Radiation Therapy in Renal Cell Carcinoma
Feat.
J. Shiao
17:31
The University of Kansas Cancer Center
Updates in Renal Cell Carcinoma
Feat.
S. Abbasi
13:37
SIR 2023 Conference Coverage
SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?
Feat.
N. Kothary
14:36
OncoAlert
RCC Updates: Perioperative Treatment, Metastatic ccRCC, and Non-Clea…
Feat.
T. Choueiri
10:29
UC Irvine Health
Molecular Characteristics of Advanced ccRCC Harboring TERT Mutations
Feat.
N. Mar
15:35
Dana-Farber Cancer Institute
Updates on the Management of Non-Clear Cell RCC
Feat.
B. McGregor
07:39
Total Health
2023 Case-Based Clinical Updates in RCC: 69 y/o Male With Clear Cell…
Feat.
D. Vaena
15:50
Pavlos Msaouel
First-Line Treatment Options in Advanced RCC: How to Choose
15:17
ASCO GU 2023 Conference Coverage
ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…
Feat.
T. Zhang
56:06
Yale Cancer Center
Determinants of Effective Anti-Tumor Immunity in Kidney Cancer
Feat.
D. Braun
14:14
PrecisCa
GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After…
Feat.
M. Rettig,
S. Slovin,
T. Fraum,
J. Abel,
P. Patel
08:16
PrecisCa
Preferred Modality for Follow-Up Imaging After Definitive Treatment …
Feat.
C. Lynn Siegel
20:23
Aly-Khan A. Lalani
Choosing Wisely: 1L Combination Treatment for Advanced RCC
10:55
Yale Cancer Center
Systemic Therapies for Clear Cell RCC: Where Are We Now?
Feat.
D. Braun